In another study, Han et al. developed a sophisticated AFM-based technique to evaluate the amyloid precursor protein (APP) cleavage mechanism at the nanomolecular level, as the clarification of the APP cleavage mechanism is crucial for the development of new AD therapeutic agents [216]. Here, APP is linked to Alzheimer disease.